Will 2026 See a ‘ChatGPT Moment’ for Microchip Implants?

The article explores whether 2026 could be a tipping point for human microchip and brain-computer interface implants, referencing Neuralink’s production ambitions, funding for Altman’s Merge, early medical use cases, and new state efforts to restrict mandatory workplace implants. It examines privacy, surveillance, and ethical concerns, public sentiment around implant-based payments, and the risk that optional technologies may evolve into defaults or mandates, ultimately urging caution despite potential medical benefits.